Pascal Obong Bessong is a microbiologist, virologist, and bioethicist whose academic and professional journey spans France, Nigeria, South Africa, and the United States. He holds a PhD in Microbiology, an MSc in Medical Microbiology and Parasitology, and an MSc in Medicine in Bioethics and Health Law.
Professor Bessong has demonstrated exceptional leadership in capacity building, having successfully supervised 60 doctoral and master’s graduates, thereby strengthening biomedical research expertise across Africa. He is an elected member of the Academy of Science of South Africa, holds a B-2 rating from the South African National Research Foundation (NRF), and is a recipient of the South African Medical Research Council Gold Merit Award for outstanding contributions to health research.
A recognized leader in global health research, Professor Bessong’s work addresses critical priorities such as antimicrobial resistance, pathogen surveillance, child health, human capital development, and community engagement. His research and opinions have been published in leading journals, including Science, Nature, Lancet HIV, Lancet Global Health, PLOS Medicine, AIDS Research and Human Retroviruses, PNAS, Bulletin of the World Health Organization, and the South African Journal of Science.
He currently serves as:
• Founding Director, South African Medical Research Council – University of Venda Antimicrobial Resistance and Global Health Research Unit
• Founding Director, Institute for Pathogen and Global Health Research, University of Venda
• DSTI/NRF South African Research Chair, Community Antimicrobial Resistance
In addition to his leadership roles at the University of Venda, Professor Bessong is a Visiting Scholar at the Center for Global Health Equity, University of Virginia; an Honorary Professor at the University of KwaZulu-Natal’s School of Health Sciences; and Associate Editor of the South African Journal of Science.
Through these roles, he continues to shape research agendas, build research capacity in Africa, foster international collaborations, and advance strategies to combat antimicrobial resistance and improve global health outcomes.
